Development and Implementation of a Tool for the Evaluation and Monitoring of the Mediterranean Lifestyle in the Clinical Setting
Launched by UNIVERSIDAD AUTONOMA DE MADRID · Sep 13, 2024
Trial Information
Current as of July 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on creating and testing an online app designed to help patients follow a Mediterranean lifestyle, which includes healthy eating, physical activity, and social habits. The app aims to support individuals who have experienced heart-related issues, like a heart attack or stroke, by providing personalized recommendations based on their habits. By using this app, participants can track their health over time, engage in discussions with healthcare providers about improving their lifestyle, and ultimately work towards reducing obesity, a major risk factor for further heart problems.
To be eligible for this trial, participants need to be between 18 and 75 years old and have had a heart-related event. They should also be able to understand and complete questionnaires and have lived in Spain for at least a year. Throughout the study, participants will have their health monitored at different points (3, 6, and 8 months) to see how their lifestyle changes affect their overall well-being. This is an exciting opportunity for individuals looking to improve their health and reduce the risk of future heart issues while contributing to valuable research.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age over 18 years and below 75 years.
- • Absence of language barriers
- • To be included in the cardiac rehabilitation programme
- • Capacity to comprehend, and answer the questionnaires, as well as to sign the informed consent.
- • Being a Spanish resident for a period of at least 1 year prior to the beginning of the study.
- • Not planning to permanently reside outside of Spain within the year.
- • Having suffered from a cardiovascular event (myocardial infarction, ictus, angina, ischemic cardiopathy).
- Exclusion Criteria:
- • Limitation to adhering to the recommendations.
- • Severe risk factors and/or with complicated control.
- • Chronic diseases not related to coronary disease (severe mental illness, congenital, susceptible to decompensation endocrinopathies, and gastrointestinal diseases with diarrhoea).
- • Patients that have an alternative private health insurance that doesn´t allow an electronic access to their data.
About Universidad Autonoma De Madrid
The Universidad Autónoma de Madrid (UAM) is a prestigious higher education institution located in Spain, renowned for its commitment to research and innovation in the biomedical field. With a strong emphasis on advancing scientific knowledge and improving healthcare outcomes, UAM actively sponsors clinical trials that explore novel therapies and interventions. The university's collaborative approach fosters partnerships with leading healthcare institutions and researchers, ensuring rigorous study design and ethical standards. UAM's dedication to excellence in clinical research contributes significantly to the advancement of medical science and the enhancement of patient care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Huelva, , Spain
Huelva, Andalucía, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported